JCCVS
Journal of Cardiology & Cardiovascular Surgery

Journal of Cardiology & Cardiovascular Surgery scientific, open-access, double-blind peer-reviewed journal covering a wide spectrum of topics in cardiology and cardiovascular surgery.

eISSN: 2980-1397
Creative Commons CC BY-NC-ND 4.0 International License.
EndNote Style

Online Manuscript System

Index
Original Article
Facilitating factors of venous risk among patients diagnosed with pulmonary thromboembolism followed in different clinical settings
Abstract
Aims: This study aims to analyze the risk factors contributing to the development of pulmonary thromboembolism (PTE) from a multidisciplinary perspective, focusing on clinical, demographic, and laboratory variables that may influence venous thrombosis pathogenesis. By elucidating the interrelationships among these factors, the study seeks to support preventive strategies and provide a scientific basis for diagnostic and management processes.
Methods: This study was conducted through a systematic evaluation of the diagnostic data—including clinical, laboratory, and imaging findings—of individuals aged 18 to 80 years who were followed for pulmonary thromboembolism between 2023 and 2025 at the Chest Diseases, Cardiovascular Surgery, and Internal Medicine departments of xxx xxx University Research and Training Hospital. Patients with uncertain diagnoses, individuals under 18 years of age, and those who received only prophylactic treatment were excluded. Imaging data (thoracic CT angiography, scintigraphy, abdominal CT, and venous Doppler ultrasound) were analyzed based on prior reports without performing any additional procedures. Clinical variables such as smoking status, comorbid conditions, surgical history, immobility, and hormonal factors in female patients, along with laboratory parameters including complete blood count, biochemistry, blood gas analysis, and D-dimer levels, were reviewed retrospectively.
Results: A total of 41 patients (25 female, 16 male) diagnosed with PTE were evaluated. The mean age of participants was 61.59 ± 17.92 years. The average age was 62.56 ± 17.93 years in women and 60.06 ± 18.40 years in men. Among 11 patients with available data on body mass index (BMI), the mean BMI was 29.97 ± 3.05. Of these, 5 were overweight, 5 had class 1 obesity, and 1 had class 2 obesity. The most common comorbidities included hypertension (n=24), diabetes mellitus (n=10), coronary artery disease (n=7), and hyperlipidemia (n=4). Among the 4 smokers, the average consumption was calculated as 21 pack-years. Surgical history was present in 17.1% of cases, and a history of immobilization was identified in 14.6%. Malignancy was observed in 2.4%, history of pregnancy in 4.9%, and oral contraceptive use in 2.4% of the patients. Genetic mutations related to hereditary thrombophilia were found in 19.5% of patients. Laboratory analyses revealed a mean hemoglobin level of 13.25 ± 2.12 g/dL, significantly lower than the reference range (p = 0.0225). Blood urea nitrogen (BUN) was elevated, with a mean level of 27.16 ± 10.43 mg/dL (p = 0.0004). Arterial blood gas analysis showed a mean sO² of 74.92 ± 12.35%, pO² of 52.21 ± 10.87 mmHg, and pCO² of 30.26 ± 6.14 mmHg, all significantly below normal reference values (p < 0.0001). The mean D-dimer level was 3.31 ± 2.36 µg/mL (p < 0.001). According to CT angiography, bilateral embolism was observed in 15 patients, segmental/lobar embolism in 14, and multiple emboli in 12. Deep vein thrombosis (DVT) was detected in 4 patients via Doppler ultrasound, while 21 patients showed no evidence of DVT.
Conclusion: This study underscores the multifactorial etiopathogenesis of pulmonary thromboembolism and emphasizes the importance of a personalized and holistic evaluation approach in diagnosis and treatment. Risk factors such as age, obesity, comorbidities, surgical history, immobility, and genetic predisposition were shown to be significant contributors to PTE development. Low hemoglobin levels and marked hypoxemia-hypocapnia reflected the systemic impact of the condition, while elevated D-dimer levels and CT angiography findings played a crucial role in early diagnosis. The findings highlight that integrating clinical, laboratory, and radiological data within a multidisciplinary framework can enhance risk stratification and improve patient outcomes.

Keywords : Pulmonary thromboembolism, venous thromboembolism, risk factors

Download Article


1. Torbicki A, Perrier A, Konstantinides S, et al. Guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J. 2008;29(18):2276-2315. doi:10.1093/eurheartj/ehn310
2. Konstantinides SV, Meyer G, Becattini C, et al. 2019 ESC guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur Heart J. 2020;41(4):543-603. doi:10.1093/eurheartj/ehz405
3. Geerts WH, Bergqvist D, Pineo GF, et al. Prevention of venous thromboembolism: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition). Chest. 2008;133(6 Suppl): 381S-453S. doi:10.1378/chest.08-0656
4. Spyropoulos AC, Anderson FA. Predictive and associative models to identify hospitalized medical patients at risk for VTE. Chest. 2011; 140(3):706-714. doi:10.1378/chest.10-1944
5. Khorana AA, Kuderer NM, Culakova E, Lyman GH, Francis CW. Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood. 2008;111(10):4902-4907. doi:10.1182/blood-2007-10-116327
6. Heit JA, Kobbervig CE, James AH, Petterson TM, Bailey KR, Melton LJ 3rd. Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study. Ann Intern Med. 2005;143(10):697-706. doi:10.7326/0003-4819-143-10-200511150-00006
7. Stein PD, Beemath A, Olson RE. Obesity as a risk factor in venous thromboembolism. Arch Intern Med. 2005;165(13):1527-1531. doi:10. 1001/archinte.165.13.1527
8. Kujovich JL. Thrombophilia and pregnancy complications. Genet Med. 2011;13(1):1-16. doi:10.1097/GIM.0b013e3181ff67cc
9. Pomp ER, le Cessie S, Rosendaal FR, Doggen CJ. Risk of venous thrombosis: obesity and its interaction with coagulation abnormalities and oral contraceptive use. Thromb Haemost. 2007;98(1):61-63. doi:10. 1111/j.1365-2141.2007.06780.x
10. Heit JA. Epidemiology of venous thromboembolism. Nat Rev Cardiol. 2015;12(8):464-474. doi:10.1038/nrcardio.2015.83
11. Cushman M. Epidemiology and risk factors for venous thrombosis. Semin Hematol. 2007;44(2):62-69. doi:10.1053/j.seminhematol.2007.02.004
12. Anderson FA Jr, Spencer FA. Risk factors for venous thromboembolism. Circulation. 2003;107(23 Suppl 1):I9-I16. doi:10.1161/01.CIR.0000078469. 07362.E6
13. Middeldorp S. Inherited thrombophilia: a double-edged sword. Hematology Am Soc Hematol Educ Program. 2016;2016(1):1-9. doi:10. 1182/asheducation-2016.1.1
14. Crous-Bou M, Harrington LB, Kabrhel C. Environmental and genetic risk factors associated with venous thromboembolism. Semin Thromb Hemost. 2016;42(8):808-820. doi:10.1055/s-0036-1592333
15. Franco RF, Reitsma PH. Genetic risk factors of venous thrombosis. Hum Genet. 2001;109(4):369-384. doi:10.1007/s004390100593
16. Zöller B, Svensson PJ, Dahlbäck B, Lind-Hallden C, Hallden C, Elf J. Genetic risk factors for venous thromboembolism. Expert Rev Hematol. 2020;13(9):971-981. doi:10.1080/17474086.2020.1804354
17. Wada H, Hatada T. Hemostatic abnormalities in the acute phase of trauma. Thromb Res. 2010;126(1):1-2. doi:10.1016/j.thromres.2009.10.013
18. Righini M, Van Es J, Den Exter PL,et al. Age-adjusted D-dimer cutoff levels to rule out pulmonary embolism: the ADJUST-PE study. JAMA. 2014;311(11):1117-1124. doi:10.1001/jama.2014.2135
19. Wells PS, Anderson DR, Rodger M, et al. Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis. N Engl J Med. 2003; 349(13):1227-1235. doi:10.1056/NEJMoa023153
20. Elias A, Mallett S, Daoud-Elias M, Poggi JN, Clarke M. Prognostic models in acute pulmonary embolism: a systematic review and meta-analysis. BMJ Open. 2016;6(4):e010324. doi:10.1136/bmjopen-2015- 010324
21. Ortel TL, Neumann I, Ageno W, et al. ASH 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism. Blood Adv. 2020;4(19):4693-4738. doi:10.1182/bloodadvances.2020001830
22. Casalini E. Role of low-osmolality contrast media in thromboembolic complications: scanning electron microscopy study. Radiology. 1992; 183(3):741-744. doi:10.1148/radiology.183.3.1584930
23. Stein PD, Fowler SE, Goodman LR, et al. Multidetector computed tomography for acute pulmonary embolism. N Engl J Med. 2006; 354(22):2317-2327. doi:10.1056/NEJMoa052367
24. Barbar S, Noventa F, Rossetto V, et al. A risk assessment model for identifying hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score. J Thromb Haemost. 2010;8(11):2450-2457. doi:10.1111/j.1538-7836.2010.04044.x
25. Cohn SL. Prophylaxis of venous thromboembolism in the US: improving hospital performance. J Thromb Haemost. 2009;7(9):1437-1445. doi:10.1111/j.1538-7836.2009.03533.x
26. James AH. Venous thromboembolism in pregnancy. Arterioscler Thromb Vasc Biol. 2009;29(3):326-331. doi:10.1161/ATVBAHA.109.184127
27. Kalaitzopoulos DR, Panagopoulos C, Samant S, et al. Management of venous thromboembolism in pregnancy. Thromb Res. 2022;211:106-113. doi:10.1016/j.thromres.2022.02.002
28. Baglin T, Gray E, Greaves M, et al. Clinical guidelines for testing for heritable thrombophilia. Br J Haematol. 2010;149(2):209-220. doi:10. 1111/j.1365-2141.2009.08022.x
29. Carson JL, Kelley MA, Duff A, et al. The clinical course of pulmonary embolism. N Engl J Med. 1992;326(19):1240-1245. doi:10.1056/NEJM 199205073261902
30. Laporte S, Mismetti P, Décousus H, et al. Clinical predictors for fatal pulmonary embolism: findings from the RIETE Registry. Circulation. 2008;117(13):1711-1716. doi:10.1161/CIRCULATIONAHA.107.726232
31. Jaff MR, McMurtry MS, Archer SL, et al. Management of massive and submassive pulmonary embolism, iliofemoral DVT, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association. Circulation. 2011;123(16):1788-1830. doi:10.1161/CIR.0b013e318214914f
32. Kabrhel C, Courtney DM, Camargo CA Jr, et al. Factors associated with positive D-dimer results in patients evaluated for pulmonary embolism. Acad Emerg Med. 2010;17(6):589-597. doi:10.1111/j.1553-2712.2010. 00765.x
33. Zuin M, Nohria A, Henkin S, Krishnathasan D, Sato A, Piazza G. Pulmonary embolism-related mortality in patients with cancer. JAMA Netw Open. 2025;8(2):e2460315. doi:10.1001/jamanetworkopen.2024. 60315
34. Pastori D, Cormaci VM, Marucci S, et al. A comprehensive review of risk factors for venous thromboembolism: from epidemiology to pathophysiology. Int J Mol Sci. 2023;24(4):3169. doi:10.3390/ijms 24043169
35. Hayssen H, Cires-Drouet R, Englum B, et al. Systematic review of venous thromboembolism risk categories derived from the Caprini score. J Vasc Surg Venous Lymphat Disord. 2022;10(6):1401-1409. doi:10. 1016/j.jvsv.2022.05.003
36. Chen Q, van Rein N, Scheres LJ, et al. Incidence, risk factors, and mortality of pulmonary embolism in the Netherlands (2015-22): sex differences and shifts during the coronavirus disease 2019 pandemic. Eur Heart J. 2025;46(28):2809-2821. doi:10.1093/eurheartj/ehaf211
37. Hasegawa D, Sato R, Lee YI, et al. The prevalence, risk factors, and outcomes of acute pulmonary embolism complicating sepsis and septic shock: a national inpatient sample analysis. Sci Rep. 2024;14(1):16049. doi:10.1038/s41598-024-67105-7
Article available in :
Volume 3, Issue 3, 2025
Page : 50-55
https://doi.org/10.51271/JCCVS-0058
Article Information
Received : 08 Ağu 2025
Accepted : 25 Eyl 2025
Published : 27 Eyl 2025
Corresponding Author :

Ümmühan Tuğba Tümüklü: Department of Pulmonology, Faculty of Medicine, Yozgat Bozok University, Yozgat, Turkiye

[email protected]
Citation : Tümüklü ÜT, Kerestecioğlu C, Felek D. Facilitating factors of venous risk among patients diagnosed with pulmonary thromboembolism followed in different clinical settings. J Cardiol Cardiovasc Surg. 2025;3(3):50-55.

Read: 132
Download : 38
Cited: 0
_Footer